0 Views
0 Connections
0 Citations
0 Reanalyses
0 Downloads
Ontology highlight
ABSTRACT: Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole.
PROVIDER: PRJNA324235 | ENA |
REPOSITORIES: ENA
ACCESS DATA
